Collegium Pharmaceutical, Inc. COLL Acquisition date fair value of contingent consideration
Acquisition date fair value of contingent consideration at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept coll:ContingentConsiderationFairValueDisclosureClassifiedAsNonCashActivity.
The official record: Collegium Pharmaceutical, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s acquisition date fair value of contingent consideration.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s acquisition date fair value of contingent consideration?
- Collegium Pharmaceutical, Inc. (COLL) reported acquisition date fair value of contingent consideration of $0 in Q4 2025.
- How has Collegium Pharmaceutical, Inc.'s acquisition date fair value of contingent consideration changed year-over-year?
- Collegium Pharmaceutical, Inc.'s acquisition date fair value of contingent consideration decreased by 100.0% year-over-year, from $1.02M to $0.
- What does acquisition date fair value of contingent consideration mean?
- This represents the estimated fair value of potential future payments to sellers of acquired businesses, contingent upon the achievement of specific performance milestones or financial targets. It serves as a measure of the company's long-term obligations tied to inorganic growth strategies. Changes in this value reflect management's updated expectations regarding the success and integration of acquired assets.